Cargando…
Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii
Emergence of multidrug-resistant Acinetobacter baumannii (MDRAB) has become a critical clinical problem worldwide and limited therapeutic options for infectious diseases caused by MDRAB. Therefore, there is an urgent need for the development of new antimicrobial agents or alternative therapy to comb...
Autores principales: | Lin, Chun-Hsien, Lee, Mong-Chuan, Tzen, Jason T.C., Lee, Hsien-Ming, Chang, Sam-Min, Tu, Wu-Chun, Lin, Chuen-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478288/ https://www.ncbi.nlm.nih.gov/pubmed/28663698 http://dx.doi.org/10.1016/j.sjbs.2016.12.013 |
Ejemplares similares
-
Antimicrobial Susceptibility Patterns of an Emerging Multidrug Resistant Nosocomial Pathogen: Acinetobacter baumannii
por: Tewari, Rachna, et al.
Publicado: (2018) -
Genome Sequences of Multidrug-Resistant Acinetobacter baumannii Strains from Nosocomial Outbreaks in Japan
por: Suzuki, Masato, et al.
Publicado: (2013) -
Development of Bactericidal Peptides against Multidrug-Resistant Acinetobacter baumannii with Enhanced Stability and Low Toxicity
por: Hazam, Prakash Kishore, et al.
Publicado: (2022) -
Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR Acinetobacter baumannii: In silico, in vitro and in vivo Studies
por: Hassan, Afreenish, et al.
Publicado: (2021) -
Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)